Danaher Bets Big on Bioprocessing—Will Resilient Demand Outpace Market Headwinds?

Danaher Corporation’s second-quarter 2025 results provided a comprehensive view of their financial performance, strategic initiatives, and market positioning. The quarter was marked by notable achievements and some challenges, set within a complex macroeconomic environment. From a financial perspective, Danaher reported sales of $5.9 billion, with core revenue growth of 1.5% year-overyear. The gross profit margin stood at 59.3%, and the adjusted operating profit margin was flat at 27.3% compared to the previous year. Adjusted diluted net earnings per share increased by approximately 5% to $1.80. Danaher’s free cash flow for the quarter was $1.1 billion, with a year-to-date conversion ratio of 143% of net income to free cash flow. While these numbers reflect a solid performance, particularly in a challenging operating environment, the core revenue growth rate suggests slower momentum compared to previous periods.